Steve Salzberg proposed, in essence, bypassing phase 3 trials for a COVID-19 vaccine. It was a very bad idea for a number of reasons. To his credit, Steve later admitted his mistake.
Yale epidemiology professor Harvey Risch published an embarrassingly bad op-ed in Newsweek defending hydroxychloroquine to treat COVID-19. It reminded me how much acupuncture and hydroxychloroquine believers have in common.
I got it wrong about something. It turns out that recent Lancet hydroxychloroquine study was likely fraudulent, thanks to a small, very dodgy company called Surgisphere. Here, I admit and explain my error and try to set things right.
Recently, President Trump introduced Operation Warp Speed, promising a coronavirus vaccine by the end of the year. Even pro-vaccine advocates—especially pro-vaccine advocates—worry that we’re moving too fast.
A new study of #Hydroxychloroquine and #Chloroquine to treat #COVID19 was published this morning in The Lancet. The results? More deaths and arrhythmias in treated patients. [NOTE ADDENDUM: This study has been retracted. Here’s a link to my followup post.]